MedTrace Logo

A Study of the Use of Text Message Reminders to Take Palbociclib

NCT04216576 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-03-27

No results posted yet for this study

Summary

The purpose of this study is to find out whether it is feasible (acceptable to participants) to use a smartphone app to send text message reminders to take palbociclib, and whether these reminders are effective at helping people remember to take palbociclib according to the treatment schedule.

Conditions

Interventions

OTHER

Paper Drug Diary

Participants will receive and use a paper Drug Diary and a paper medication calendar.

OTHER

OhMD APP

Participants will receive multiple text messages regarding administration over time on medication self-management over the course of 3 cycles of medication

Sponsors & Collaborators

Principal Investigators

  • Margaret Barton-Burke, PhD, RN · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-27
Primary Completion
2026-12-27
Completion
2026-12-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04216576 on ClinicalTrials.gov